https://www.marketscreener.com/quote/stock/CANTARGIA-AB-31837413/news/Cantargia-Reports-New-Preclinical-Data-Confirming-the-Potential-of-Nadunolimab-and-Can10-45436630/?utm_source=telegram&utm_medium=social&utm_campaign=share